Evidence-based early stage type 2 diabetes follow-up in Belgian primary care practices: Impact of multi-professional teams and care protocols

2020 ◽  
Author(s):  
Evi Matthys ◽  
Peter Van Bogaert ◽  
Sabrina Blommaert ◽  
Liesbeth Verdonck ◽  
Roy Remmen
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Early Stage ◽  
Evidence Based ◽  
Care Practices ◽  
Primary Care Practices

scholarly journals Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany

2016 ◽  
Vol 11 (2) ◽  
pp. 272-277 ◽  
Author(s):  
Qing Qiao ◽  
Kristina Johnsson ◽  
Susan Grandy ◽  
Karel Kostev
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Treatment Outcomes ◽  
Receptor Agonist ◽  
Baseline Hba1c ◽  
Care Practices ◽  
Primary Care Practices ◽  
Diabetes Patients

Background: The aim was to investigate real-world treatment outcomes and tolerability of GLP-1 receptor agonist (GLP-1RA) therapy in patients with type 2 diabetes in Germany. Methods: Patients from 323 primary care practices who started any GLP-1RA therapy (89 Byetta, 108 Bydureon, 347 Victoza patients) between January 1, 2011, and December 31, 2013 (index date) were analyzed retrospectively (Disease Analyzer database, Germany). Changes from baseline in HbA1c, weight, and hypoglycemia were evaluated in 3 follow-up periods of 0-6, 7-12, and 13-18 months. Results: A total of 544 diabetes patients (mean age: 57.9 years; men: 54%) were eligible for the study. Mean (SD) HbA1c (%) decreased from 8.3 (1.4) at baseline to 7.4 (1.2) in 6 months, 7.6 (1.3) in 7-12 months and 7.6 (1.4) in 13-18 months, respectively ( P < .001 for all), while the proportion of patients with HbA1c <7% increased from 15% at baseline to 38%, 36% and 35% in the corresponding periods ( P < .0001 for all). Multivariate-adjusted beta coefficients corresponding to changes in HbA1c (%) from baseline were –.52, –.44, and –.44, respectively, in the follow-up periods for baseline HbA1c (%) ( P < .0001 for all). The prevalence of hypoglycemia at baseline was 0.7%; this did not change significantly after treatment. Conclusions: In clinical practice, GLP-1RA treatment was associated with improved glycemic control without increased hypoglycemia for up to 18 months. The higher the baseline HbA1c, the greater the HbA1c reduction recorded.

Feasibility and Effectiveness of System Redesign for Diabetes Care Management in Rural Areas

2005 ◽  
Vol 31 (5) ◽  
pp. 712-718 ◽  
Author(s):  
Paul Bray ◽  
Melissa Roupe ◽  
Sandra Young ◽  
Jolynn Harrell ◽  
Doyle M. Cummings ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Primary Care ◽  
Type 2 Diabetes Mellitus ◽  
Case Management ◽  
Minority Population ◽  
Group Visits ◽  
Care Practices ◽  
Primary Care Practices

Purpose Redesigning the system of care for the management of patients with type 2 diabetes mellitus has not been well studied in rural communities with a significant minority population and limited health care resources. This study assesses the feasibility and potential for cost-effectiveness of restructuring care in rural fee-for-service practices for predominantly minority patients with diabetes mellitus. Methods This was a feasibility study of implementing case management, group visits, and electronic registry in 5 solo or small group primary care practices in rural North Carolina. The subjects were 314 patients with type 2 diabetes mellitus (mean age = 61 years; 72% African American; 54% female). An advanced practice nurse visited each practice weekly for 12 months, provided intensive diabetes case management, and facilitated a 4-session group visit educational program. An electronic diabetes registry and visit reminder systems were implemented. Results There was an improvement in the percentage of patients achieving diabetes management goals and an improvement in productivity and billable encounters. The percentage of patients with a documented self-management goal increased from 0% to 42%, a currently documented lipid panel from 55% to 76%, currently documented aspirin use from 25% to 37%, and currently documented foot examination from 12% to 54%. The average daily encounter rate improved from 20.17 to 31.55 on intervention days. Conclusions A redesigned care delivery system that uses case management with structured group visits and an electronic registry can be successfully incorporated into rural primary care practices and appears to significantly improve both care processes and practice productivity.

Low annual frequency of HbA1ctesting in people with Type 2 diabetes in primary care practices in Germany

2017 ◽  
Vol 35 (2) ◽  
pp. 249-254 ◽  
Author(s):  
K. Kostev ◽  
L. Jacob ◽  
A. Lucas ◽  
W. Rathmann
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Annual Frequency ◽  
Care Practices ◽  
Primary Care Practices

Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care

2021 ◽  
pp. 193229682199872
Author(s):  
Gregg D. Simonson ◽  
Richard M. Bergenstal ◽  
Mary L. Johnson ◽  
Janet L. Davidson ◽  
Thomas W. Martens
Keyword(s):  
Type 2 Diabetes ◽  
Primary Care ◽  
Glucose Monitoring ◽  
Care Model ◽  
Time In Range ◽  
Glucose Management ◽  
The Impact ◽  
Primary Care Management

Background: Little data exists regarding the impact of continuous glucose monitoring (CGM) in the primary care management of type 2 diabetes (T2D). We initiated a quality improvement (QI) project in a large healthcare system to determine the effect of professional CGM (pCGM) on glucose management. We evaluated both an MD and RN/Certified Diabetes Care and Education Specialist (CDCES) Care Model. Methods: Participants with T2D for >1 yr., A1C ≥7.0% to <11.0%, managed with any T2D regimen and willing to use pCGM were included. Baseline A1C was collected and participants wore a pCGM (Libre Pro) for up to 2 weeks, followed by a visit with an MD or RN/CDCES to review CGM data including Ambulatory Glucose Profile (AGP) Report. Shared-decision making was used to modify lifestyle and medications. Clinic follow-up in 3 to 6 months included an A1C and, in a subset, a repeat pCGM. Results: Sixty-eight participants average age 61.6 years, average duration of T2D 15 years, mean A1C 8.8%, were identified. Pre to post pCGM lowered A1C from 8.8% ± 1.2% to 8.2% ± 1.3% (n=68, P=0.006). The time in range (TIR) and time in hyperglycemia improved along with more hypoglycemia in the subset of 37 participants who wore a second pCGM. Glycemic improvement was due to lifestyle counseling (68% of participants) and intensification of therapy (65% of participants), rather than addition of medications. Conclusions: Using pCGM in primary care, with an MD or RN/CDCES Care Model, is effective at lowering A1C, increasing TIR and reducing time in hyperglycemia without necessarily requiring additional medications.

scholarly journals Translating Evidence-Based Depression Management Services to Community-Based Primary Care Practices

2004 ◽  
Vol 82 (4) ◽  
pp. 631-659 ◽  
Author(s):  
AMY M. KILBOURNE ◽  
HERBERT C. SCHULBERG ◽  
EDWARD P. POST ◽  
BRUCE L. ROLLMAN ◽  
BEA HERBECK BELNAP ◽  
...  
Keyword(s):  
Primary Care ◽  
Evidence Based ◽  
Community Based ◽  
Depression Management ◽  
Care Practices ◽  
Primary Care Practices ◽  
Management Services
Sign in / Sign up

Export Citation Format

Share Document